•
Sep 30, 2018

Outlook Therapeutics Q4 2018 Earnings Report

Total Revenue
$772K
Previous year: $2.9M
-73.4%
EPS
$0.4
Previous year: -$6.2
-106.5%
Gross Profit
$0
0
Cash and Equivalents
$1.72M
Previous year: $3.19M
-46.1%
Free Cash Flow
-$9.66M
Previous year: $55.9K
-17383.5%
Total Assets
$22.3M
Previous year: $20.7M
+7.5%

Outlook Therapeutics

Outlook Therapeutics